Rosetta Genomics Ltd ROSGQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.04
- Market Cap
- $592.99
- Volume/Avg
- 11,036 / 8,851
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 86
- Website
- http://www.rosettagenomics.com
Valuation
|
Metric
|
ROSGQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ROSGQ
|
|---|---|
Quick Ratio | 0.85 |
Current Ratio | 2.09 |
Interest Coverage | — |
Quick Ratio
ROSGQ
Profitability
|
Metric
|
ROSGQ
|
|---|---|
Return on Assets (Normalized) | −93.61% |
Return on Equity (Normalized) | −161.02% |
Return on Invested Capital (Normalized) | −148.92% |
Return on Assets
ROSGQ
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Bqtzgyjfq | Vjdjd | $209.3 Bil | |
DHR
| Danaher Corp | Bqykzrcrxk | Rhydz | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Lqnwjdhcc | Pqdgf | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Mwdkgxrhm | Pkfkf | $41.0 Bil | |
A
| Agilent Technologies Inc | Pxwylmnn | Gdn | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Csvnvrzvm | Swgvf | $26.4 Bil | |
ICLR
| Icon PLC | Yxdtckmz | Qktxww | $25.2 Bil | |
ILMN
| Illumina Inc | Jkhpdnh | Xmyvdf | $19.6 Bil | |
WAT
| Waters Corp | Mcxpzbdd | Xhfcd | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Btkbgtnkt | Hqvgg | $17.5 Bil |